NRC expected to issue Mo-99 facility license for Shine in 2021

May 13, 2020, 9:10PMNuclear News

Shine Medical Technologies, which is building a medical isotope production facility in Janesville, Wis., said on May 11 that it expects to have an operating license issued by the Nuclear Regulatory Commission by October 2021. Shine’s application seeking approval to operate the facility, which will produce isotopes including molybdenum-99, was accepted and docketed by the NRC last October. Mo-99, the precursor to technetium-99m, is used in more than 40 million medical patient procedures every year.

To continue reading, log in or create a free account!

Related Articles

The DOE’s plan for AI in NRC licensing

April 2, 2026, 9:40AMNuclear News

The Department of Energy announced the completion of a proof-of-concept demonstration of the use of Everstar’s AI tool to generate chapter 5 of an NRC license application from preliminary...

NRC adopts ROP updates

March 30, 2026, 3:14PMNuclear News

The Nuclear Regulatory Commission has approved a significant overhaul of its Reactor Oversight Process (ROP) baseline inspection program that stresses a leaner, more risk-focused inspection...